Gabriel Cohn - Net Worth and Insider Trading
Gabriel Cohn Net Worth
The estimated net worth of Gabriel Cohn is at least $136 dollars as of 2024-06-10. Gabriel Cohn is the Chief Medical Officer of Homology Medicines Inc and owns about 146 shares of Homology Medicines Inc (FIXX) stock worth over $136. Details can be seen in Gabriel Cohn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gabriel Cohn has not made any transactions after 2022-01-05 and currently still holds the listed stock(s).
Transaction Summary of Gabriel Cohn
Gabriel Cohn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gabriel Cohn owns 1 companies in total, including Homology Medicines Inc (FIXX) .
Click here to see the complete history of Gabriel Cohn’s form 4 insider trades.
Insider Ownership Summary of Gabriel Cohn
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FIXX | Homology Medicines Inc | 2022-01-05 | Chief Medical Officer |
Gabriel Cohn Latest Holdings Summary
Gabriel Cohn currently owns a total of 1 stock. Gabriel Cohn owns 146 shares of Homology Medicines Inc (FIXX) as of January 5, 2022, with a value of $136.
Latest Holdings of Gabriel Cohn
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FIXX | Homology Medicines Inc | 2022-01-05 | 146 | 0.93 | 136 |
Holding Weightings of Gabriel Cohn
Gabriel Cohn Form 4 Trading Tracker
According to the SEC Form 4 filings, Gabriel Cohn has made a total of 1 transactions in Homology Medicines Inc (FIXX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Homology Medicines Inc is the sale of 92 shares on January 5, 2022, which brought Gabriel Cohn around $6,279.
Insider Trading History of Gabriel Cohn
- 1
Gabriel Cohn Trading Performance
Gabriel Cohn Ownership Network
Gabriel Cohn Owned Company Details
What does Homology Medicines Inc do?
Who are the key executives at Homology Medicines Inc?
Gabriel Cohn is the Chief Medical Officer of Homology Medicines Inc. Other key executives at Homology Medicines Inc include director & President & CEO Arthur Tzianabos , See Remarks Paul Alloway , and Chief Scientific Officer Albert Seymour .
Homology Medicines Inc (FIXX) Insider Trades Summary
Over the past 18 months, Gabriel Cohn made no insider transaction in Homology Medicines Inc (FIXX). Other recent insider transactions involving Homology Medicines Inc (FIXX) include a net sale of 21,335 shares made by Paul Alloway , a net sale of 23,653 shares made by Arthur Tzianabos , and a net sale of 5,068 shares made by Albert Seymour .
In summary, during the past 3 months, insiders sold 0 shares of Homology Medicines Inc (FIXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,328 shares of Homology Medicines Inc (FIXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,328 shares.
Homology Medicines Inc (FIXX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Homology Medicines Inc Insider Transactions
Gabriel Cohn Mailing Address
Above is the net worth, insider trading, and ownership report for Gabriel Cohn. You might contact Gabriel Cohn via mailing address: C/o Homology Medicines, Inc., One Patriots Park, Bedford Ma 01730.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
